摘要
目的 :观察益芪口服液治疗缺血中风急性期气虚血瘀型患者证候积分的影响。方法 :采用简单随机法 ,将符合标准的病例接受益芪组或对照组的治疗 ,试验组 (益芪组 )接受基础治疗 +试验药物 (益芪口服液 ) ,对照组接受基础治疗 ;治疗 14天评价神经功能缺损积分值的改变 ,随访 1个月 (30± 2天 )进行总的生活能力状态 (ADL)评定。结果 :治疗组 (益芪组 )32例 ,对照组 31例 ,两组基线基本一致 ;治疗 14天中风病证候积分改变比较 ,组间气虚血瘀证、气虚证、血瘀证积分改变比较 ,差异有显著性意义 (P <0 .0 5~ 0 .0 1) ,益芪组优于对照组 ;组内证候积分改变比较 ,益芪组气虚证、血瘀证证候积分改变比较 ,差异有显著性意义 (P <0 .0 5 ) ,气虚证改善优于血瘀证。结论 :初步说明益芪方对气虚血瘀证缺血中风的治疗干预是有效的 ,同时提出在气虚证、血瘀证证候积分改善方面的疗效差异的可能原因。
OBJECTIVE: To evaluate effect on syndrome of patients with acute cerebral infarction and qi-deficiency, blood-stasis in TCM with Yiqi Power. METHOD:The patients was randomly divided into group A or group B at the ratio of 1:1, group A received Yiqi power and basic therapy, and patients in group B only received basic therapy, for 2 weeks. RESULTS:32 patients in group A, 31 patients in group B, effect of syndrome of qi-deficiency, blood-stasis in TCM in the group A was more superior to that of the control group B at 14d after treatment (P<0.05). CONCLUSION:These results demonstrate that Yiqi power has superiority to the basic therapy in improving effect on syndrome of patients with acute ischemic stroke and qi-deficiency, blood-stasis in TCM.
出处
《湖南中医药导报》
2003年第5期9-11,共3页
Hunan Guiding Journal of Traditional Chinese Medicine and Pharmacology
关键词
缺血中风
气虚血瘀
益芪口服液
证候
Acute ischemic infarction
Qi-deficiency, Blood-stasis in TCM
Yiqi power
Syndrome